(Q38099513)

28 August 2017

title

Autophagy: a new target or an old strategy for the treatment of Crohn's disease? (English)

1 reference

28 August 2017

0 references

0 references

3

1 reference

28 August 2017

Patrizia Agostinis

2

0 references

author name string

Kris Nys

series ordinal

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

16 April 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

395-401

1 reference

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy: renovation of cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy protects against Sindbis virus infection of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Listeria monocytogenes ActA-mediated escape from autophagic recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Toll-like receptor 4 is a sensor for autophagy associated with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Toll-like receptors control autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy-dependent viral recognition by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Regulation of inflammasome signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A role for mitochondria in NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

The contribution of autophagy to lymphocyte survival and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Intestinal epithelial cells with impaired autophagy lose their adhesive capacity in the presence of TNF-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Is the autophagy induced by thiopurines beneficial or deleterious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy and the integrated stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Use of complementary and alternative medicine by patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Anti-tumour and antioxidant activity of natural curcuminoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Plasmodium falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Paradoxical aspects of rapamycin immunobiology in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Use of sirolimus (rapamycin) to treat refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

mTOR and metabolic pathways in T cell quiescence and functional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Towards a novel molecular classification of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Biological therapies for inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Using genetic information for the identification, classification and treatment of Crohn’s disease: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

The genetics of inflammatory bowel disease: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Deconvoluting the context-dependent role for autophagy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Management of ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

The potential for disease modification in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

New drug therapies on the horizon for IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Shigella phagocytic vacuolar membrane remnants participate in the cellular response to pathogen invasion and are regulated by autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Impaired autophagy leads to abnormal dendritic cell-epithelial cell interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.66

How tumour necrosis factor blockers interfere with tuberculosis immunity.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23591407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hydroxychloroquine (Plaquenil) for recurrence prevention of Crohn's disease after curative surgery

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23591407

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2013.66

1 reference

28 August 2017

1 reference